Venclexta 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F4G0M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,830
Award facts
- Contract value 100% obligated
- $51,830.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,830.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of Venclexta 100 mg tablets in quantities of 120 units. The contract utilizes a firm fixed-price structure with no set-aside designation, indicating open competition. Performance will be completed by February 19, 2026, at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031.
AmerisourceBergen serves as a critical pharmaceutical distributor supporting the Defense Logistics Agency's medical supply chain, providing brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military healthcare systems and federal medical institutions. The Venclexta order represents a routine task order execution under the parent company's comprehensive pharmaceutical supply vehicle, which enables efficient delivery of essential oncology and specialty medications required by military treatment facilities and veterans' healthcare programs globally. The contract's firm fixed-price structure and expedited completion timeline reflect standard procurement practices for essential pharmaceutical commodities within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F4G0M?
SPE2DR26F4G0M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4G0M worth?
The government has obligated $51,830 on SPE2DR26F4G0M.
Is contract SPE2DR26F4G0M an order under another contract?
Yes. SPE2DR26F4G0M is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4G0M competed?
The extent of competition for SPE2DR26F4G0M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award